Mirae Asset Global Etfs Holdings Ltd. Lucid Diagnostics Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $56.2 Billion
- Q3 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Lucid Diagnostics Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 31,863 shares of LUCD stock, worth $34,412. This represents 0.0% of its overall portfolio holdings.
Number of Shares
31,863
Previous 37,768
15.63%
Holding current value
$34,412
Previous $43,000
25.58%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding LUCD
# of Institutions
84Shares Held
32.3MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA4.52MShares$4.89 Million0.0% of portfolio
-
Masters Capital Management LLC Atlanta, GA4MShares$4.32 Million0.15% of portfolio
-
Abrdn PLC3.46MShares$3.73 Million0.01% of portfolio
-
Two Seas Capital LP Rye, NY3MShares$3.24 Million0.06% of portfolio
-
Awm Investment Company, Inc. New York, NY2.99MShares$3.23 Million0.37% of portfolio
About Lucid Diagnostics Inc.
- Ticker LUCD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 38,568,500
- Market Cap $41.7M
- Description
- Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease, which is also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarc...